Neuroprotective effects of vitamin C on hypoxic-ischemic brain injury in neonatal mice

Area of Science:

• Neuroscience
• Developmental Biology
• Pharmacology

Background:

• Hypoxic ischemia (HI) is a primary cause of neonatal brain injury, leading to severe neurodevelopmental disorders.
• Conditions like cerebral palsy, epilepsy, and cognitive deficits stem from neonatal brain damage.
• This study investigates the potential of vitamin C as a neuroprotective agent against HI-induced brain injury in neonates.

Purpose of the Study:

• To evaluate the neuroprotective efficacy of vitamin C in a neonatal mouse model of hypoxic-ischemic brain injury.
• To assess the impact of vitamin C on brain damage markers, neuroinflammation, and functional recovery post-HI injury.

Main Methods:

• Neonatal mice at postnatal day 7 underwent hypoxic-ischemic (HI) brain injury.
• Mice received daily vitamin C treatment for seven consecutive days post-HI.
• Evaluations included brain damage assessment, sensorimotor function tests in neonates, and learning/memory tests in adulthood.

Main Results:

• Vitamin C administration significantly decreased hippocampal damage, infarction volume, and neuronal loss.
• Treatment with vitamin C effectively suppressed neuroinflammation following HI injury.
• Mice treated with vitamin C demonstrated improved sensorimotor function and enhanced learning and memory capabilities.

Conclusions:

• Vitamin C demonstrates significant neuroprotective effects in the neonatal hypoxic-ischemic brain damage (HIBD) model.
• Treatment with vitamin C promotes functional recovery, including improved sensorimotor and cognitive abilities.
• Vitamin C presents a promising therapeutic candidate for clinical trials targeting hypoxic-ischemic encephalopathy.